Table of Contents
ISRN Cardiology
Volume 2011 (2011), Article ID 740585, 5 pages
http://dx.doi.org/10.5402/2011/740585
Research Article

Insulin Receptor Substrate-1 Expression Is Increased in Circulating Leukocytes of Patients with Acute Coronary Syndrome

1Department of Cardiology, Hospital Clínico Universitario Virgen de la Victoria, 29010 Málaga, Spain
2Department of Cardiology, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain
3Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain
4Department of Epidemiology, Atherothrombosis and Imaging, Spanish National Cardiovascular Research Center (CNIC), 28029 Madrid, Spain
5Instituto de Biomedicina de Valencia (IBV), Spanish Council for Scientific Research (CSIC) and Fundación Investigación Hospital Clínico de Valencia, Av. Blasco Ibáñez, 46010 Valencia, Spain

Received 21 February 2011; Accepted 20 April 2011

Academic Editor: K. Nakamura

Copyright © 2011 Manuel F. Jiménez-Navarro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. R. Moreno and V. Fuster, “New aspects in the pathogenesis of diabetic atherothrombosis,” Journal of the American College of Cardiology, vol. 44, no. 12, pp. 2293–2300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Murcia, C. H. Hennekens, G. A. Lamas et al., “Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction,” Archives of Internal Medicine, vol. 164, no. 20, pp. 2273–2279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Hasin, M. Hochadel, A. K. Gitt, S. Behar, H. Bueno, and Y. Hasin, “Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus,” The American Journal of Cardiology, vol. 103, no. 6, pp. 772–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Beckman, M. A. Creager, and P. Libby, “Diabetes and atherosclerosis epidemiology, pathophysiology, and management,” Journal of the American Medical Association, vol. 287, no. 19, pp. 2570–2581, 2002. View at Google Scholar · View at Scopus
  5. H. Gonzalez-Navarro, A. Vinue, M. Vila-Caballer et al., “Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 12, pp. 2187–2194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Burks, J. F. De Mora, M. Schubert et al., “IRS-2 pathways integrate female reproduction and energy homeostasis,” Nature, vol. 407, no. 6802, pp. 377–382, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Kubota, K. Tobe, Y. Terauchi et al., “Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia,” Diabetes, vol. 49, no. 11, pp. 1880–1889, 2000. View at Google Scholar
  8. D. J. Withers, J. S. Gutierrez, H. Towery et al., “Disruption of IRS-2 causes type 2 diabetes in mice,” Nature, vol. 391, no. 6670, pp. 900–904, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Baumgartl, S. Baudler, M. Scherner et al., “Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis,” Cell Metabolism, vol. 3, no. 4, pp. 247–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Gonzalez-Navarro, M. Vila-Caballer, M. F. Pastor et al., “Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice,” Frontiers in Bioscience, vol. 12, pp. 2291–2298, 2007. View at Google Scholar · View at Scopus
  11. S. B. Harrap, K. S. Zammit, Z. Y. H. Wong et al., “Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 874–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Gunton, R. N. Kulkarni, S. Yim et al., “Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes,” Cell, vol. 122, no. 3, pp. 337–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Morgan, L. Xiao, P. Lyons, B. Kassebaum, H. M. Krumholz, and J. A. Spertus, “Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome,” BMC Medical Genetics, vol. 9, article 66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. A. Amorim, T. D. Nguyen, Y. Shingu et al., “Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression,” The Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 5, pp. 1160–1166, 2010. View at Publisher · View at Google Scholar